Page last updated: 2024-10-17

cytosine and Dermatomyositis

cytosine has been researched along with Dermatomyositis in 2 studies

Dermatomyositis: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Saraeva, R1
Kamenarska, Z1
Dourmishev, L1
Vinkov, A1
Dzhebir, G1
Kachakova, D1
Ivanova, N1
Pozharashka, J1
Kaneva, R1
Hristova, M1
Tubridy, N1
Wells, C1
Lewis, D1
Schon, F1

Other Studies

2 other studies available for cytosine and Dermatomyositis

ArticleYear
    Immunological investigations, 2022, Volume: 51, Issue:4

    Topics: CD3 Complex; Cytosine; Dermatomyositis; DNA Methylation; Genotype; Guanine; Humans; Phosphates; Poly

2022
Unsuccessful treatment with cidofovir and cytarabine in progressive multifocal leukoencephalopathy associated with dermatomyositis.
    Journal of the Royal Society of Medicine, 2000, Volume: 93, Issue:7

    Topics: Adult; Antiviral Agents; Cidofovir; Cytarabine; Cytosine; Dermatomyositis; Drug Therapy, Combination

2000